Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2002, 5AM Ventures is a life science venture capital firm based in the United States. The firm focuses on funding and building next-generation life sciences companies, with a notable emphasis on early-stage investments. 5AM Ventures manages a portfolio that includes several significant funding rounds in the biotech sector.
5AM Ventures primarily invests in private therapeutic companies, concentrating on early-stage investments, particularly Series A financing. The firm also engages in public equity investments in small and mid-cap biotech and life science companies, aiming to support innovative solutions in the life sciences sector.
Notable portfolio companies include Mendra, which launched with an $82 million Series A to develop therapeutics for rare diseases; Precede Biosciences, which secured $83.5 million for a precision diagnostics platform; Kinaset Therapeutics, which announced a $103 million oversubscribed Series B for a novel inhaled therapeutic candidate; and CAMP4, which entered a strategic collaboration with GSK for RNA-based therapeutic discoveries.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.